Patient-Centric Innovation in Orphan Drug Development

Discover how patient-centered design is shaping the future of orphan drug development at the Paris 2025 Congress. Sessions focus on patient engagement from preclinical stages through commercialization. Learn how lived experiences inform trial protocols, benefit-risk assessments, and post-market surveillance. Engage with pharmaceutical leaders integrating patient insights into R&D pipelines and regulatory submissions. Explore tools for co-creating therapies, improving adherence, and enhancing patient satisfaction. Elevate your organization’s innovation process through empathy-driven, data-supported, and inclusive strategies.

    Related Conference of Patient-Centric Innovation in Orphan Drug Development

    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    June 08-09, 2026

    20th World Drug Delivery Summit

    London, UK
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Patient-Centric Innovation in Orphan Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in